115 results about "Anesthetics drugs" patented technology

An injectable formulation of a sedative hypnotic drug, such as the anesthetic drug propofol, that is pharmaceutically stable and demonstrates a reduced incidence of pain upon injection. The formulation of the present invention employs a sulfoalkyl ether cyclodextrin solubilizing and complexing excipient, such as CAPTISOL® cyclodextrin (sulfobutyl ether β-cyclodextrin) to form a true aqueous solution and not a suspension. This formulation minimizes the allergic response and microbial contamination issues typically associated with propofol parenteral formulations. The present formulation may also reduce pain on injection as compared to the known emulsion type propofol formulations. The liquid formulation can be sterile filtered unlike emulsion-type formulations of sedative hypnotics. The liquid formulation can be lyophilized or otherwise dried to yield a solid formulation.

The invention relates to a medicine access control system, in particular to an access control system for common medicines, anaesthetic medicines and consumables for operating rooms. By the medicine access control system, medicine set combinations can be provided for doctors quickly and accurately during operation, and information such as a medicine fetcher, a witness, a fetching time, the type of a medicine or a consumable, a patient taking the medicine and the like can be recorded automatically; the medicine taking situation of the patient can be recorded accurately, so that omitted records or extra records of the charge for the patient can be avoided; and medicine lack warning can be realized when the medicines and the consumables are insufficient.

A device for treating atrial fibrillation includes a pad which houses the distal end of an electrode which is adapted to deliver a substantially uniform shock gradient to an atrial surface of a postoperative cardiac patient, if atrial fibrillation is detected. The device also includes a catheter for delivering anti-arrhythmic and / or anesthetic drugs to the pad. After a treatment period, the device may be removed by pulling the electrode and the pad, if the pad is not bioabsorbable, into the catheter and then pulling the catheter through the patient's chest wall.

An apparatus comprises a data processing unit (100) which receives electroencephalographic data based on a measurement of a person (110) exposed to anesthetic drug substance which has one or more estimated or measured non-zero levels of concentration in the body (108) of the person (110) as a function of time; and determines and present activity of slow waves of the electroencephalographic data at the one or more estimated or measured levels of the non-zero concentration of the anesthetic drug substance.

The system and method includes a treatment device such as an anesthetic machine or IV, a monitor and a display configured to display real-time PK / PD data associated with an anesthetic agent administered to the patient. The system and method further includes a safety control means configured to control the display such that one of a basic display state, an interactive effects display state, and a display inhibited state is selected and displayed according to the anesthetic agents and levels of the same being administered to the patient.

The invention provides a primer set, application, a product and a method for detecting SNP sites related to drug metabolism in children, and relates to the field of biotechnology. The primer set of the SNP sites related to drug metabolism in children provided by the invention can be used to detect the metabolism capacity of thermoanalgesics, metabolism capacity of respiratory system drugs, metabolism capacity of neurological and psychiatric drugs, metabolism capacity of cardiovascular and cerebrovascular drugs, metabolism capacity of anti-infective drugs, metabolism capacity of endocrine drugs, metabolism capacity of digestion system drugs, metabolism capacity of anesthetic drugs and metabolism capacity of chemotherapy and immunosuppressant. Specific detection of site mutation related to common drug metabolism in children can be realized by the primer set, the accuracy is high, the detection cycle can be tremendously shortened, and the detection cost is reduced at the same time. Moreover, the needs of a drug metabolism can be predicted by the detection results, the metabolism capacity of a variety of drugs can also be comprehensively evaluated, and scientific reference is providedfor the individualized medication of children.

A graphical user interface for use by a clinician in the monitoring of the depth of the anesthesia of a patient. The graphical user interface comprising a drug library with data related to a plurality of anesthetic drugs, a drug administration window for displaying drug administration data, at least one window disposed for the display of a pharmacokinetic graph and a pharmacodynamic graph, and a scale selector comprising a first condition wherein the pharmacokinetic model and the pharmacodynamic models are displayed and a second condition where only the pharmacokinetic model is displayed.

A system for monitoring a concentration of an anesthetic drug using a patient's breath is provided. The system comprises a sampling subsystem for processing the patient's breath to form a breath sample, one or more sensors to measure drug concentration in the breath sample, one or more sensors to measure a concentration of gases in the breath sample; and one or more microprocessors for determining a concentration of the drug in a plasma of the patient using a transfer function and the concentration of the drug in the breath sample. A system for monitoring propofol concentration in patient's breath sample is also provided.

The invention discloses an intelligent drug cabinet based on RFID (Radio Frequency Identification Devices) and an RFID reading method of the drug cabinet. The intelligent drug cabinet comprises a cabinet body 1, a plurality of drug storage drawers 2, a main control module 3, an RFID collection terminal 4, a temperature and humidity collection terminal 5, a communication module 6, an electromagnetic lock module 7 and a mechanical lock 8. The invention also provides a method for reading protocol of an intelligent drug cabinet tube through RFID. With adoption of a manner of reading labels by using stepped radio frequency power, the reliability of identifying labels in the intelligent RFID drug cabinet is improved and the negative impact brought by multi-path effect and label angles is emphatically avoided, so that the drugs stored in the drug cabinet are managed intelligently, the supervision and management of special drugs such as toxicant drugs, anesthetic drugs, psychotropic drugs and radioactive drugs are improved, and the working efficiency of drug management is improved.

The invention discloses a concentration adjustable-type anesthesia outfit for an anesthesiology department. The concentration adjustable-type anesthesia outfit comprises an outfit body. Two sides of the bottom of the outfit body are provided with support plates. Multiple storage drawers are installed between the two support plates. The right side of the outfit body is provided with a handrail. Theupper left side of the outfit body is provided with a corner groove. The outfit body, positioned below the corner groove, is provided with an installing cavity. The concentration adjustable-type anesthesia outfit for the anesthesiology department is capable of avoiding troubles that a medical worker needs to stir distributed drugs manually, increasing a contact probability of a stirring blade andan anesthetic drug, accelerating a stirring and mixing speed of the anesthetic drug, greatly improving working efficiency, and directly transmitting the distributed anesthetic drug liquid into an anesthetic injector for anesthesia use through a drug pushing mechanism, thereby using conveniently, saving both time and labor, and relieving workload of the medical worker, and suitable for popularization and application.

The present invention is directed towards instruments and methods for discharging an anesthetic drug on a continuous basis for use as a nerve block. In accordance with the present invention, a catheter assembly is provided that comprises an electrically conductive wire, a protective sheath and an inflatable balloon. The inflatable balloon is at the distal end of the catheter capable of being inflated and deflated. A balloon channel terminates within the inflatable balloon at the distal end of the catheter and extends proximally along the length of the catheter to the proximal end of the catheter. The balloon channel has a balloon channel opening at a distal end of the balloon channel within the inflatable balloon, capable of releasing an injected substance into the inflatable balloon. The balloon channel further has a balloon channel injection opening at a proximal end of the balloon channel, capable of receiving an injected substance.

A graphical user interface for the documentation of an administered anesthetic drug and the display of an associated pharmacokinetic model and an associated pharmacodynamic model. The graphical user interface comprises a first window that displays the drug administration data, and a second window displaying a pharmacokinetic model and a pharmacodynamic model, the second window being separate and distinct from the first window. The pharmacokinetic model and the pharmacodynamic models are overlaid and displayed and the pharmacokinetic model and the pharmacodynamic model are based on the drug administration data displayed in the first window.

A system and a method for medication identification and inventory control is disclosed. The disclosed system and method were designed to track specified medications' (e.g., narcotics and controlled substances) inventory from manufacturer's lot number all the way to the use / waste stage of the medications and to provide periodic reports and notifications on the medications' usage, breakage, waste and expiration. Further, the disclosed system and method utilizes tamper evident bags with unique identifier to protect and keep accurate track of the medications.

The invention relates to a system for delivering anesthesia drugs to a patient. The system comprises means for feeding anesthesia drugs to the patient treated, a measuring device for measuring at least one parameter relating to the effects of the anesthetic drugs fed to the patient, a patient monitor to show the results measured by the measuring devices, and feeding means for feeding patient demographics to the system. The system further comprises means for visual planning of the anesthesia drug delivery before the drugs are actually fed. The system can also comprise means for anesthesia management for drug interaction during the treatment.

According to one aspect, the fibers of a muscle to be shortened or lengthened are exposed to a local anesthetic drug such as bupivacaine. The concentration and volume of the local anesthetic drug are sufficient to causes the muscle fibers to be damaged by the myotoxicity of the drug. The muscle is then kept at a different length, shorter or longer, during the ensuing period of muscle fiber regeneration, resulting in a shortened or lengthened muscle. In one embodiment, the shortened length of the treated muscle improved the position and the movement of the eye to which it was attached.

The invention relates to a system for delivering anesthesia drugs to a patient. The system comprises means for feeding anesthesia drugs to the patient treated, a measuring device for measuring at least one parameter relating to the effects of the anesthetic drugs fed to the patient, a patient monitor to show the results measured by the measuring devices, and feeding means for feeding patient demographics to the system. The system further comprises means for visual planning of the anesthesia drug delivery before the drugs are actually fed. The system can also comprise means for anesthesia management for drug interaction during the treatment.

The invention discloses a drug-loaded composite hernia patch and a preparation method thereof. The composite hernia patch comprises a polylactic acid / polypropylene skin-core structure fiber substrateand a drug-loaded slow-release layer which are combined together through hot pressing. The invention further provides a preparation method of the composite hernia patch. The method comprises the following steps: 1) preparing developer-doped polypropylene; 2) preparing polylactic acid / polypropylene skin-core structure fibers, and performing weaving to obtain the substrate; 3) preparing drug-loadedmicrospheres of an antibacterial drug, a hemostatic drug and an anesthetic drug; 4) preparing the drug-loaded slow-release layer through electrostatic spinning; and 5) performing hot pressing to obtain the finished product. The drug-loaded composite hernia patch avoids the problem of adhesion caused by direct contact between a polypropylene material and tissues, meanwhile, different drugs can be added to the drug-loaded slow-release layer according to needs, surgical healing is promoted, the polylactic acid material can be slowly degraded and absorbed in vivo, and discomfort of the patch is reduced after healing.

The invention discloses a double-compartment injection device, which comprises a syringe, a push rod, a push handle and a needle head. The push rod is arranged in the syringe, a rubber head is arranged at one end of the push rod, and a push handle is arranged at the other end. The head is located in the syringe, and the edge of the end of the syringe is provided with a connecting tube, wherein, there are two cavities inside the needle, and a chute is provided on the outer wall of the syringe, the number of the syringe is two, and the two needles The barrels are inserted and locked with each other through the chute, and the connecting tubes of the two syringes are juxtaposed together, and the two connecting tubes are respectively inserted and connected with the two cavities on the needle head. The outer wall of the syringe is provided with scale lines, the push handle is provided with anti-slip texture, and the syringe is a transparent plastic product. Needle length 6cm. The invention has the advantages of simple structure and convenient use, and can inject two kinds of anesthetic drugs with different concentrations through one puncture, which is beneficial to anesthesia operation.

The invention provides an anesthetic dosage determination method, a model training method and a model. The method comprises the steps of collecting the current physical sign of an anesthetized person;and processing the current physical sign, the historical physical sign of the anesthetized person at the same historical moment and the historical dosage of the anesthetic drug through a preset anesthetic drug calculation model, and determining the current dosage of the anesthetic drug matched with the current physical sign. Due to the fact that the anesthetic drug has a residual effect in the body, the amount of the anesthetic drug needing to be injected at a certain moment needs to depend on the physical sign of the anesthetized person at the current moment and also needs to refer to the historical physical sign of the anesthetized person at the same historical moment and the historical dosage of the anesthetic drug. Therefore, by processing the current physical sign of the anesthetizedperson, the historical physical sign at the same historical moment and the historical dosage of the anesthetic drug, it can be determined that the current dosage of the anesthetic drug conforms to the dosage required by the current physical sign of the anesthetized person, so that the dosage of the anesthetic drug can be accurately predicted.

The invention discloses an inhalational anesthetic device for experimental animals, comprising a housing, an anesthetic chamber, an intake pipe, and a return gas pipe, as well as an anesthetic gas source; a pressure sensing device is arranged within the housing and includes a bearing plate, a spring, a rheostat and a controller, one end of the spring is fixed to the inner wall of the housing, theother end of the spring is connected with the bearing plate, the rheostat is connected to the bottom face of the bearing plate and is connected with the controller, a front end opening of the housingis connected with the intake pipe, a rear end opening of the housing is provided with a rear end cover that is threaded connection or fastened connection, the rear end cover is connected with an inlethood, and the edge of the inlet hood covers the inner side of the rear end cover. The inhalational anesthetic device for experimental animals has the advantages that anesthetic gas is distributed evenly in the anesthetic chamber to arrive at optimal fastest anesthesia; anesthetic condition is judged according to movement state of an animal, anesthesia is stopped in time, harm to the animal due toinhalation of excess of an anesthetic drug is relieved; the inhalational anesthetic device for experimental animals is good in tightness and causes less harm of anesthetics to experimental staff.

The invention belongs to the technical field of medicine management, and discloses an anesthetic medicine management system which comprises an operation medicine kit, an operation medicine box storage unit, a medicine storage unit, an identity recognition unit, a medicine cabinet lock control unit, a package cabinet lock control unit, a medicine cabinet gravity sensing unit and a processing unit. The processing unit can recognize and read and write a first identification chip, and synchronizes the medicine use information to the corresponding operation medicine kit; and compares the number of the medicine allocated by the medicine storage unit with the number of the hollow bottles recycled to the operation medicine kit after use in the medicine storage unit according to the number of the medicine allocated by the medicine storage unit, judges whether the number of the taken medicine is consistent with the number of the empty medicine bottles or not, and if not, gives a feedback through the alarm unit. The anesthetic medicine management system enables the operation room toxic and anesthetic medicine management and the operation medicine kit management to be more intelligent.

The invention discloses an intelligent management cabinet for poisonous and anesthetic drugs, which comprises a cabinet body, a control assembly and a plurality of drug storage cells, and is characterized in that each drug storage cell is controlled to be opened and locked through an electromagnetic lock; the control assembly comprises a touch screen computer and an identity recognizer, and the identity recognizer and the electromagnetic lock are both connected with the touch screen computer; the touch screen computer can achieve the following steps that when identity information input by an anesthesia nurse is detected, the identity information is verified, and the corresponding drug storage cells are opened after the identity information passes verification; after the drug is replaced, the taking permission of each drug storage cell input by the anesthesia nurse is obtained; when the identity information input by an anesthetist is detected, the identity information is verified, and the operation room number, the drug box and drug types and the base number corresponding to the authority of the anesthetist are displayed after the verification is passed; and after confirmation operation of the anesthetist is received, the corresponding drug storage cells are opened. The system achieves the intelligent management of toxic and numb drugs, and improves the work efficiency.

Disclosed is a Propofol emulsion and its preparing method, which comprises intralipid, volatile general anesthetic and venous general anesthetic propofol of formulation concentration, the medicine can rapidly deepen general anesthesia and has the advantages of fast anaesthetic speed, less toxic and side effects, and extracorporeal circulation application.

The system and method includes a treatment device such as an anesthetic machine or IV, a monitor and a display configured to display real-time PK / PD data associated with an anesthetic agent administered to the patient. The system and method further includes a safety control means configured to control the display such that one of a basic display state, an interactive effects display state, and a display inhibited state is selected and displayed according to the anesthetic agents and levels of the same being administered to the patient.

Provided is a multifunctional urethral detector, including a main tube body, wherein one end, inserted into the urethra, of the main tube body is taken as the outer end; a separation strip is arrangedin the main tube body in the length direction, and divides the cavity of the main tube body into an injection chamber and an installation chamber; the outer wall of the main tube body is provided with a plurality of medicine outlet holes, and all the medicine outlet holes are communicated with the medicine injection cavity; a plurality of medicine outlet holes are arranged side by side and spacedapart along the length direction of the main tube body; the radius of the medicine outlet holes from the inner end of the main tube body to the outer end of the main tube body is gradually reduced, and the outer end of the main body is connected with a medicine injection tube connected with the medicine injection cavity; and a first valve body is arranged on the medicine injection tube; In summary, the multifunctional urethral detector can detect the pressure and temperature of the urine in the urethra, can judge whether the urethra is obstructed or not by detecting the pressure, can judge whether there is bacterial infection in the urethra by detecting the temperature, can directly display the pressure and the temperature value through the display, and can alleviate the pain of the patient by injecting the anesthetic drug into the urethra, and the whole device is reasonable in design and strong in practicability.

The invention relates to a device for uniformly mixing anesthetic gas and detecting the concentration of the anesthetic gas. The device comprises a buffer mixing device and a detection device; the buffer mixing device is connected with the detection device through an air channel, the buffer mixing device is used for receiving anesthetic gas in the anesthesia machine and mixing the anesthetic gas,and the detection device is used for detecting the concentration of the anesthetic mixed gas coming out of a first anesthetic mixed gas outlet. Compared with the prior art, the gas contact area is increased through the spiral bent pipe, anesthetic gas is further mixed evenly through the convection principle, and the anesthetic drug concentration detection precision is improved. Gas is uniformly mixed by arranging a pure mechanical structure with two gas paths, extra energy does not need to be provided, energy consumption is reduced, and practicability is achieved.

The invention provides a use system and method for toxic anesthetic drugs. A first sensing device in the use system senses the RFID information of the toxic anesthetic drugs pasted with RFID tags, and displays the sensed RFID information to a first terminal device; the second sensing device senses the RFID information of the poison anesthetic to be used and displays the sensed RFID information to the second terminal equipment; the second terminal equipment binds the RFID information of the to-be-used toxic anesthetic drugs with the information of the medicine taking patient; and empty bottle information in the empty bottle recycling bin is sensed through the radio frequency sensing device, and the empty bottle information is uploaded to the second terminal equipment. According to the mode, the RFID information of the toxic anesthetic drugs is established, one-code lifelong management of a single toxic anesthetic drug is realized, and through high automation and intelligentization of RFID information reading, manual errors in use and handover processes are avoided, and malignant events such as unclear drug flow and private drug storage are avoided.

The invention is directed to an analgesia and / or an anesthesia drug / device, system and an analgesic and / or an anaesthetic method utilizing a drug storage bag prefilled pharmaceutically or in a pharmaceutical compounding facility with a drug which system or method involves long-term stability of the thug prefilled storage bag, thus enabling the simplification of both, home treatment and hospital treatment procedures, in particular, the system or method is utilizing a storage bag comprising multi-layered flint. the surface of which is drug-compatible while subsequent layers constitute a barrier against any gases, e.g. oxygen, carbon dioxide, water vapour and / or humidity, and optionally ultraviolet radiation. This system and method comprises preferably a label / marking, providing information in a visual and / or wireless way to the pump system and the supporting services, directly or through the internet, in order to avoid medical errors regarding the administration of analgesic and / or anesthetics drugs. The system and method also enables for the unlocking of any drug prefilled storage bag, preferably a drug cassette, which is protected against abuse.

The invention relates to the technical field of materials for neurosurgery, in particular to a self-adhesive hemostatic artificial dura mater repair patch and a preparation method thereof. The repairpatch comprises an artificial dura mater substrate which is a porous sponge structure substrate, the surface of the substrate is coated with an adhesive layer, and the used adhesive is chitosan and / orhyaluronic acid. The preparation method comprises the following steps: separately or proportionally mixing the chitosan and hyaluronic acid, and dissolving the obtained mixture in deionized water toprepare an aqueous solution with a certain concentration; coating the surface of the artificial dura mater substrate with the aqueous solution to form the adhesive layer with a certain thickness; andfreezing the artificial dura mater to dry the adhesive layer on the surface to form the self-adhesive hemostatic artificial dura mater repair patch. The repair patch can simplify the dura mater repairprocess in an operation, reduce the requirements for the technology of doctors, improve the water tightness of dura mater repair, has a hemostatic function, shortens the operation time, reduces the application of anesthetic drugs and the pain of patients, and reduces the corresponding medical expenses.

The invention belongs to the technical field of medicine identification, and discloses an operating room anesthetic medicine identification system, which comprises a user verification login module, a medicine image acquisition module, a character extraction module, a medicine type determination module, a central control module, an RFID marking module, a medicine rechecking module, an operation information acquisition module, an anesthetic medicine selection module and an RFID identification module. According to the invention, the login safety is ensured through multiple verification, and the management safety of the anesthetic drug database and the anesthetic drug repository is better; the information such as the name of the anesthetic medicine is obtained by identifying characters on the outer package of the anesthetic medicine, and the information corresponding to the anesthetic medicine is conveniently obtained during scanning by marking the information through the RFID tag, so that the anesthetic medicine is identified more accurately and conveniently; besides, the anesthetic is accurately obtained through recognition, so that the anesthesia environment in the operation can be smoothly carried out, and the complex operation of manually checking the anesthetic is reduced.